Literature DB >> 9384994

Course of psychiatric disorders across the menstrual cycle.

V Hendrick1, L L Altshuler, V K Burt.   

Abstract

Women of reproductive age with psychiatric disorders may experience a fluctuating course of illness over the menstrual cycle. Some data suggest an exacerbation of symptoms during the premenstrual and menstrual phases. The usefulness of such reports is limited, however, by the lack of prospective assessments and the small number of patients involved. Additionally, many reports do not specify whether the exacerbations reflect an intensification of the underlying psychiatric disorder or a new onset of symptoms that occur only during certain phases of the menstrual cycle. Because symptomatic intensification has been reported for illnesses including schizophrenia, bipolar disorder, depression, anxiety disorders, bulimia nervosa, and substance abuse, the data bring attention to the importance of assessing the relationship between a female patient's symptomatic exacerbation and the menstrual-cycle phase in which it occurs. We present a review of the literature on the course of psychiatric symptoms across the menstrual cycle and discuss the potential effects of estrogen and progesterone on these symptoms.

Entities:  

Mesh:

Year:  1996        PMID: 9384994     DOI: 10.3109/10673229609030544

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  18 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

2.  The role of sex steroids in forming anxiety states in female mice.

Authors:  A Yu Galeeva; P Tuohimaa; V G Shalyapina
Journal:  Neurosci Behav Physiol       Date:  2003-05

3.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

4.  Involvement of nuclear progesterone receptors in the formation of anxiety in female mice.

Authors:  A Yu Galeeva; S G Pivina; P Tuohimaa; N E Ordyan
Journal:  Neurosci Behav Physiol       Date:  2007-10

5.  Menstrual effects on mood symptoms in treated women with bipolar disorder.

Authors:  Dorothy Sit; Howard Seltman; Katherine L Wisner
Journal:  Bipolar Disord       Date:  2011-05       Impact factor: 6.744

6.  Examination of the stability of the anxiety sensitivity index across the menstrual cycle in trauma-exposed women with and without PTSD.

Authors:  Yael I Nillni; Kim A Arditte Hall; Kirsten J Langdon; Suzanne L Pineles
Journal:  Anxiety Stress Coping       Date:  2019-08-27

7.  Progesterone reduces hyperactivity of female and male dopamine transporter knockout mice.

Authors:  Cheryl A Frye; Ichiro Sora
Journal:  Behav Brain Res       Date:  2010-01-20       Impact factor: 3.332

8.  Impact of reproductive status and age on response of depressed women to cognitive therapy.

Authors:  Anna R Brandon; Abu Minhajuddin; Michael E Thase; Robin B Jarrett
Journal:  J Womens Health (Larchmt)       Date:  2013-01       Impact factor: 2.681

Review 9.  The Impact of the Menstrual Cycle and Underlying Hormones in Anxiety and PTSD: What Do We Know and Where Do We Go From Here?

Authors:  Yael I Nillni; Ann M Rasmusson; Emilie L Paul; Suzanne L Pineles
Journal:  Curr Psychiatry Rep       Date:  2021-01-06       Impact factor: 5.285

10.  Progesterone and Cerebral Function during Emotion Processing in Men and Women with Schizophrenia.

Authors:  Julie Champagne; Nadia Lakis; Josiane Bourque; Emmanuel Stip; Olivier Lipp; Adrianna Mendrek
Journal:  Schizophr Res Treatment       Date:  2012-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.